Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 730-738

  Chaudhry, Farooq A ^a   Tauke, Jason T ^a   Alessandrini, Renato S ^a   Vardi, Gil ^a   Parker, Michele A ^a   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CHRONIC DISEASE; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROGNOSIS; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032860029     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00252-1     Document Type: Article

References (59)

1. Bruschke A.V.G., Proudfit W.L., Sones F.M. Progress study of 590 consecutive nonsurgical cases of coronary artery diseased followed 5-9 years II. ventriculographic and other correlations . Circulation. 47:1973;1154-1163.
2. Hammermeister K.E., DeRouen T.A., Dodge H.T. Variables predictive of survival in patients with coronary disease selection by univariate and multivariate analysis from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations . Circulation. 59:1979;421-430.
3. Harris P.J., Harrel F.E., Lee K.L., et al. Survival in medically treated coronary artery disease. Circulation. 60:1979;1259-1269.
4. Mock M.B., Ringqvist I., Fisher L.D., et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation. 66:1982;562-568.
5. Emond M., Mock M.B., Davis K.B., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 90:1994;2645-2657.
6. Braunwald E., Rutherford J.D. Reversible ischemic left ventricular dysfunction evidence for "hibernating" myocardium . J Am Coll Cardiol. 8:1986;1467-1470.
7. Rahimtoola S.H. The hibernating myocardium. Am Heart J. 117:1989;211-213.
8. Rozanski A., Bernard D., Gray R., et al. Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography. N Engl J Med. 307:1982;212-215.
9. Brundage B.H., Massie B.M., Botvinick E.H. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 3:1984;902-908.
10. Dilsizian V., Bonow R.O., Cannon R.O., et al. The effect of coronary artery bypass grafting on left ventricular systolic function at rest evidence for preoperative subclinical myocardial ischemia . Am J Cardiol. 61:1988;1248-1254.
11. Elefteriades J.A., Tolis G. Jr, Levi E., et al. Coronary artery bypass grafting in severe left ventricular dysfunction excellent survival with improved ejection fraction and functional state . J Am Coll Cardiol. 22:1993;1411-1417.
12. Eitzman D., Al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 20:1992;559-565.
13. Di Carli M.F., Davidson M., Little R., et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
14. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction relative efficacy of medical therapy and revascularization . Circulation. 90:1995;2687-2694.
15. Pierard L.A., De Lansheere C.M., Berthe C., et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
16. Barilla F., Gheorghiade M., Alam M., et al. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J. 122:1991;1522-1531.
17. Cigarroa C.G., deFilippi C.R., Brickner E., et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 88:1993;430-436.
18. Marzullo P., Parodi O., Reisenhofer B., et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol. 71:1993;166-172.
19. La Canna G., Alfieri O., Giubbini R., et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
20. Charney R., Schwinger M., Chung J., Cohen M.V. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J. 128:1994;864-869.
21. Baer F.M., Voth E., Deutsch H.J., Schneider C.A., et al. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 24:1994;343-353.
22. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation optimal dose and accuracy in predicting recovery of ventricular function after coronary revascularization . Circulation. 91:1995;663-670.
23. Panza J.A., Dilsizian V., Laurienzo J.M., et al. Relation between thallium uptake and contractile response to dobutamine implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction . Circulation. 91:1995;990-998.
24. Perrone-Filardi P., Pace L., Prastaro M., et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation. 91:1995;2556-2565.
25. 201Tl single-photon emission computed tomography . Circulation. 91:1995;2748-2752.
26. deFellipi C.R., Willet D.R., Irani W.N., et al. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation. 92:1995;2863-2868.
27. Haque T., Furukawa T., Takahashi M., Knioshita M. Identification of hibernating myocardium by dobutamine stress echocardiography comparison with thallium-201 reinjection imaging . Am Heart J. 130:1995;553-563.
28. Vanoverschelde J.J., D'Hondt A.M., Marwick T., et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 28:1996;432-442.
29. Skopicki H.A., Abraham S.A., Weissman N.J., et al. Factors influencing regional myocardial contractile response to inotropic stimulation analysis in humans with stable ischemic disease . Circulation. 94:1996;643-650.
30. Gerber B.L., Vanoverschelde J.L.J., Bol A., et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction implications for the pathophysiology of chronic myocardial hibernation . Circulation. 94:1996;651-659.
31. Bax J.J., Cornel J.H., Visser F.C., et al. Prediction of recovery of regional ventricular dysfunction following revascularization comparison of F18-fluorodeoxyglucose SPECT, thallium stress-reinjection SPECT and dobutamine echocardiography . J Am Coll Cardiol. 28:1996;558-564.
32. Perrone-Filardi P., Pace L., Prastaro M., et al. Assessment of myocardial viability in patients with chronic coronary artery disease rest-4 hour-24 hour thallium-201 tomography versus dobutamine echocardiography . Circulation. 94:1996;2712-2719.
33. Sawada S., Elsner G., Segar D.S., et al. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol. 29:1997;55-61.
34. 201Tl uptake and comparative prediction of recovery of function . Circulation. 95:1997;626-635.
35. Lee H.A., Davila-Roman V.G., Ludbrook P.A., et al. Dependency of contractile reserve on myocardial blood flow implications for the assessment of myocardial viability with dobutamine stress echocardiography . Circulation. 96:1997;2884-2891.
36. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
37. Chen C., Li L., Chen L.L., et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 92:1995;756-766.
38. Folland E.D., Parisi A.F., Moynihan P.F., Jones D.R., Feldman C.L., Tow D.E. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. Circulation. 60:1979;760-766.
39. Cox D.R. Regression models and life tables. J R Stat Soc [B]. 34:1972;187-200.
40. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
41. Lee E.T. Statistical Methods for Survival Data Analysis. 2nd ed. 1992;John Wiley, New York.
42. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444.
43. Dilsizian V., Bonow R.O. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation. 87:1993;1-20.
44. Tillisch J.H., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
45. Maddahi J., Schelbert H., Brunken R., Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med. 35:1994;707-715.
46. Dilsizian V., Rocco T.P., Freedman N.M.T., et al. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146.
47. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
48. Udelson J.E., Coleman P.S., Matherall J.A., et al. Predicting recovery of severe regional ventricular dysfunction comparison of resting scintigraphy with thallium-201 and technetium-99m sestamibi . Circulation. 89:1994;2552-2561.
49. Maes A.F., Borgers M., Flameng W., et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT correlation with histologic and positron emission tomographic studies and functional follow-up . J Am Coll Cardiol. 29:1997;62-68.
50. 99mTc-sestamibi tomography before coronary bypass graft surgery correlation with histopathology and postoperative improvement in cardiac function . Circulation. 96:1997;2892-2898.
51. Bonow R.O. Identification of viable myocardium. Circulation. 94:1996;2674-2680.
52. Bax J.J., Wijns W., Cornel J.H., et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to coronary artery disease comparison of pooled data . J Am Coll Cardiol. 30:1997;1451-1460.
53. Williams M.J., Olabshian J., Lauer M.S., et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
54. Nesto R.W., Cohn L.H., Collins J.J., et al. Inotropic reserve a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction . Am J Cardiol. 50:1982;39-44.
55. Schwarz E.R., Schaper J., vom Dahl J., et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 27:1996;1577-1585.
56. Elasser A., Schlepper M., Klovekorn W.P., et al. Hibernating myocardium an incomplete adaptation to ischemia . Circulation. 96:1997;2920-2931.
57. Gioia G., Powers J., Heo J., Iskandrian A.S. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 75:1995;759-762.
58. Weiner D.A., Ryan T.J., McCabe C.H., et al. The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery. J Am Coll Cardiol. 8:1986;741-748.
59. Mazzotta G., Bonow R.O., Pace L., et al. Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest. J Am Coll Cardiol. 13:1989;567-573.